David Michael Johnson - 15 Jun 2022 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Director
Signature
/s/ Julie Feder, Attorney-in-fact
Issuer symbol
AURA
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 17:07:59 UTC
Previous filing
14 Jun 2022
Next filing
15 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AURA Common Stock 30,000 15 Jun 2022 Direct
holding AURA Common Stock 139,672 15 Jun 2022 By Velocity Capital Management F1
holding AURA Common Stock 10,000 15 Jun 2022 By NEJ09 IRREVOCABLE TRUST F2
holding AURA Common Stock 10,000 15 Jun 2022 By NEJ12 IRREVOCABLE TRUST F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURA Stock Option (Right to Buy) Award $0 +16,000 $0.000000 16,000 15 Jun 2022 Common Stock 16,000 $13.72 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Velosity Capital Management LLC is an entity that the reporting person is the sole member of.
F2 The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
F3 The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
F4 This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 15, 2023 or (b) the next annual meeting of the Issuer's stockholders.